NDA cCep – Drug Price Control in India: A Regulatory Perspective
Posted by By nishithadmin at 1 June, at 15 : 03 PM Print
May 22, 2020 (21:00 – 22:00 IST)
Speakers: Dr. Milind Antani, Gowree Gokhale, Darren Punnen
Kanchana TK- Director- Government affairs, Market Access, Healthcare Affairs, Institutional business Boehringer Ingelheim
MK Narayanswami – former Senior Director – Accounting and Taxation Sanofi India Limited
Currently associated as Consultant to Sanofi India and OPPI
To be our Premium Guest,
Please Register
